LAUSR

Opioids are frequently overprescribed in the postoperative setting. The opioid crisis has led to nationwide efforts to change this practice. At many institutions, opioids are routinely prescribed at discharge following lumpectomy and excisional biopsy procedures despite a paucity of evidence to support their necessity. In fact, there is evidence that a variety of ambulatory breast procedures can be adequately managed without discharge opioids. At Memorial Sloan Kettering Cancer Center, as part of a quality improvement initiative to reduce unnecessary opioid prescriptions in ambulatory breast surgery, we changed our discharge protocol to replace routinely prescribed discharge opioids with a non-steroidal anti-inflammatory drug (NSAID) (diclofenac) for patients having a lumpectomy or excisional biopsy procedure. Our study examined whether discharge with NSAID achieved comparable pain control to opioids by comparing patient-reported pain scores before and after the change from routine opioids to NSAID. PRESENT